Key facts
- This page summarizes Darlene Soave's Form 4 filing for Cell Source, Inc. (CLCS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 11 Aug 2021, 11:00.
Darlene Soave - 09 Aug 2021 Form 4 Insider Report for Cell Source, Inc. (CLCS)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- CLCS
- Reported as of
- 09 Aug 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Aug 2021, 11:00:51 UTC
- Prior SEC filing
- 07 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Darlene Soave
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Darlene Soave filed Form 4 for Cell Source, Inc. (CLCS) on 11 Aug 2021.
Change
- Previous filing in this sequence was filed on 07 Jul 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLCS
transaction
Derivative
Warrant (Option to buy)
Other
- Transaction value
- $0
- Shares
- +800,000
- Change %
- Price
- $0.000000
- Shares after
- 800,000
- Date
- 09 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 800,000
- Exercise price
- $1.25
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Issued in connection with funding of convertible note.